Not using Bio­strength for BE [Regulatives / Guidelines]

posted by jag009  – NJ, 2018-07-17 08:32 (2547 d 08:47 ago) – Posting: # 19073
Views: 2,993

Hi,

❝ Our firm is developing a multi-strength product which is a high potency, NTI oral dosage...


1) Is 0.15mg your only strength?
2) Why you want to dose 0.15x4 and not just 0.15mg?
3) Better to file a control correspondence

J

Complete thread:

UA Flag
Activity
 Admin contact
23,428 posts in 4,929 threads, 1,680 registered users;
64 visitors (0 registered, 64 guests [including 29 identified bots]).
Forum time: 17:20 CEST (Europe/Vienna)

No matter what side of the argument you are on,
you always find people on your side
that you wish were on the other.    Thomas Berger

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5